$Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial$

Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial

Despite the benefits of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin, its suitability for patients with heart failure (HF) in the real-world setting remains unclear. Considering the unique pharmacological profile of SGLT2i (e.g., glucose excretion leading to calorie loss) and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2023-01, Vol.370, p.263-270
Hauptverfasser:	Takeuchi, Shinsuke, Kohno, Takashi, Goda, Ayumi, Shiraishi, Yasuyuki, Saji, Mike, Nagatomo, Yuji, Tanaka, Toshikazu D., Takei, Makoto, Nakano, Shintaro, Soejima, Kyoko, Kohsaka, Shun, Yoshikawa, Tsutomu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Geriatric nutritional risk index Glucose Heart failure Heart Failure - diagnosis Heart Failure - drug therapy Humans Malnutrition Malnutrition - diagnosis Preserved ejection fraction Sodium-glucose cotransporter 2 inhibitor Stroke Volume Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!